; and (B) the term manufacturer means a person who is engaged in any of the activities listed in clause (A). . 1072. Determination of budgetary effects The budgetary effects of this subtitle, for the purpose of complying with the Statutory Pay-As-You-Go Act of 2010, shall be determined by reference to the latest statement titled Budgetary Effects of PAYGO Legislation for this subtitle, submitted for printing in the Congressional Record by the Chairman of the House Budget Committee, provided that such statement has been submitted prior to the vote on passage. I Advisory Committee on Immunization Practices 1081. Expedited meeting of ACIP for COVID–19 vaccines (a) In general Notwithstanding section 3091 of the 21st Century Cures Act ( 21 U.S.C. 360bbb–4 note), the Advisory Committee on Immunization Practices shall meet and issue a recommendation with respect to a vaccine that is intended to prevent or treat COVID–19 not later than 15 business days after the date on which such vaccine is licensed under section 351 of the Public Health Service Act ( 42 U.S.C. 262 ) or authorized under section 564 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360bbb–3 ). (b) Definition In this section, the term Advisory Committee on Immunization Practices means the Advisory Committee on Immunization Practices established by the Secretary of Health and Human Services pursuant to section 222 of the Public Health Service Act ( 42 U.S.C. 217a ), acting through the Director of the Centers for Disease Control and Prevention. J Improvements to Transparency of the Pricing of Diagnostic Testing for COVID–19 1091. Improvements to transparency of the pricing of diagnostic testing for COVID–19 (a) In general Section 3202 of the CARES Act ( Public Law 116–136 ) is amended— (1) in subsection (b)— (A) in the heading, by inserting and Related Items and Services after Diagnostic Testing for COVID–19